List of Oncology Medication For

Solid Tumors

Treatment for solid tumors depends on several factors, including the type and stage of the tumor, its location, and the patient’s overall health. Treatment options may include surgery to remove the tumor, chemotherapy, radiation therapy, targeted therapy, immunotherapy, or a combination of these approaches.

Tevimbra (tislelizumab-jsgr) Injection

Gastrointestinal, Lung Cancer, Solid Tumors

Brand Name: Tevimbra. Generic Name: (tislelizumab-jsgr). It is used to treat non-small cell lung cancer (NSCLC), gastric and squamous oesophageal cancer.

Tevimbra is used to treat non-small cell lung cancer (NSCLC), gastric or gastro-oesophageal junction adenocarcinoma (a type of cancer of the stomach or the transition between the stomach and oesophagus), squamous oesophageal cancer (cancer of the oesophagus, the passage from the mouth to the stomach).

Brand Name:	Tevimbra
Generic Name:	tislelizumab-jsgr
Strength:	• Injection: 100 mg/10 mL (10 mg/mL) solution in a single-dose vial
Manufacturer:	BeiGene
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “Tevimbra (tislelizumab-jsgr) Injection” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for pharma product cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

tildrakizumab-asmn injection

Skin

tildrakizumab-asmn injection
for subcutaneous use Initial U.S. Approval: 2018

tildrakizumab-asmn injectionis an interleukin-23 antagonist indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.

Facts about tildrakizumab-asmn injection

DISEASE INDICATIONS-Psoriasis
MANUFACTURER-Almirall, S.A.
USAGE-Subcutaneous
MEDICINE APPROVED BY-European Medical Agency (EMA),Food and Drug Administration (FDA).
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “tildrakizumab-asmn injection” based on the information you provide.

Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

Tirabrutinib-Tablets

Lymphoma

Velexbru Tablet 80mg,
a Bruton’s Tyrosine Kinase Inhibitor in Japan

Velexbru® Tablet 80mg, a BTK Inhibitor, for Additional Indication of Waldenstrom Macroglobulinemia and Lymphoplasmacytic Lymphoma. Velexbru (tirabrutinib hydrochloride) is a medication used for the treatment of recurrent or refractory primary central nervous system lymphoma.

Facts about tirabrutinib-tablets

Disease Indications-Lymphoma
Manufacturer-Ono Pharmaceutical Co., Ltd.
Usage-Oral
Medicine Approved By-Pharmaceuticals and Medical Devices Agency (PMDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “tirabrutinib-tablets” based on the information you provide.

Tralokinumab-ldrm Injection

Skin

tralokinumab-ldrm injection
for subcutaneous use Initial U.S. Approval: 2021

tralokinumab-ldrm injection is an interleukin-13 antagonist indicated for the treatment of moderate-to-severe atopic dermatitis in adult patients whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. ADBRY can be used with or without topical corticosteroids.

Facts about tralokinumab-ldrm injection

DISEASE INDICATIONS-Atopic Dermatitis
MANUFACTURER-Leo Pharma
USAGE-Subcutaneous
MEDICINE APPROVED BY-Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import tralokinumab-ldrm injection” based on the information you provide.

Trastuzumab Injection

Breast Cancer

trastuzumab
Intravenous Infusion Initial U.S. Approval: 1998

Herceptin is used in the treatment of early-stage breast cancer that is Human Epidermal growth factor Receptor 2-positive (HER2+) and has spread into the lymph nodes, or is HER2-positive and has not spread into the lymph nodes. It is also used in metastatic breast cancer and in gastric cancer. The patent in 2019 in the United States.

Facts about trastuzumab Intravenous Infusion

Approval Date: 1998
Proprietary Name: On Request
Active Ingredient(s): infliximab
Dosage Forms And Strengths: Multidose vial nominally containing 440 mg Herceptin as a lyophilized, sterile powder.
Company: Roche
Diseases: metastatic breast cancer and in gastric cancer
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import trastuzumab Intravenous Infusion” based on the information you provide.

TRIKAFTA (elexacaftor, tezacaftor and ivacaftor tablets; ivacaftor tablets)

Lung Cancer

TRIKAFTA (elexacaftor, tezacaftor and ivacaftor tablets; ivacaftor tablets), co-packaged for oral use.

TRIKAFTA is a combination of ivacaftor, a CFTR potentiator, tezacaftor, and elexacaftor indicated for the treatment of cystic fibrosis (CF) in patients aged 12 years and older who have at least one F508del mutation in the CFTR gene. If the patient’s genotype is unknown, an FDA-cleared CF mutation test should be used to confirm the presence of at least one F508del mutation.

Brand Name:	TRIKAFTA
Generic Name:	elexacaftor, tezacaftor and ivacaftor tablets
Strength:	• Tablets: Fixed-dose combination containing elexacaftor 50 mg, tezacaftor 25 mg and ivacaftor 37.5 mg co-packaged with ivacaftor 75 mg.
Manufacturer:	Vertex Pharmaceuticals
Approved By:	EMA, USFDA

Source content : www.accessdata.fda.gov

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import TRIKAFTA (elexacaftor, tezacaftor and ivacaftor tablets)” based on the information you provide.

trilaciclib for injection

Lung Cancer

trilaciclib for injection
for intravenous use Initial U.S. Approval: 2021

Cosela (trilaciclib) is a medication to reduce the damage done on the bone marrow by chemotherapy (myelosuppression) in adult patients with extensive-stage small cell lung cancer (ES-SCLC) prior to receiving chemotherapy.

Facts about trilaciclib for injection

Disease Indications-Lung Cancer
Manufacturer-G1 Pharmaceuticals, Inc.
Usage-Intravenous
Medicine Approved BY-Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “trilaciclib for injection” based on the information you provide.

TRODELVY (sacituzumab govitecan-hziy) for injection

Breast Cancer

Brand Name: TRODELVY Generic Name: sacituzumab govitecan-hziy. It is used to treat adults with a type of breast cancer known as triple-negative breast cancer.

TRODELVY is a Trop-2-directed antibody and topoisomerase inhibitor conjugate indicated for the treatment of adult patients with metastatic triple-negative breast cancer (mTNBC) who have received at least two prior therapies for metastatic disease.

Brand Name:	TRODELVY
Generic Name:	sacituzumab govitecan-hziy
Strength:	• For injection: 180 mg lyophilized powder in single-dose vials for reconstitution.
Manufacturer:	Gilead Sciences, Inc.
Approved By:	EMA, USFDA

Source content : www.accessdata.fda.gov

IPN, New Delhi can facilitate patient to import of “TRODELVY (sacituzumab govitecan-hziy) for injection” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for pharma product cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

TRUQAP (capivasertib) tablets

Breast Cancer, Solid Tumors

Brand Name: TRUQAP Generic Name: capivasertibb. It is used to treat breast cancer.

Truqap works to treat breast cancer by blocking the AKT enzyme. This enzyme becomes active in tumors due to unusual genes such as PIK3CA, AKT1, or PTEN. Blocking this enzyme stops the cancer from growing and spreading. * In this article, we use the terms “male” and “female” to refer to someone’s sex assigned at birth.

Brand Name:	TRUQAP
Generic Name:	capivasertib
Strength:	• Tablets: 160 mg and 200 mg
Manufacturer:	AstraZeneca
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “TRUQAP (capivasertib) tablets” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for TRUQAP (capivasertib) tablets price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

TUKYSA (tucatinib) Tablets

Breast Cancer, Colon, Gastrointestinal, Solid Tumors

Brand Name: TUKYSA. Generic Name: (tucatinib). It is used to treat breast cancer.

Tukysa is a cancer medicine that is used to treat breast cancer that is locally advanced or metastatic (has spread to other parts of the body) and when it is HER2-positive. This means the cancer cells produce a protein on their surface, HER2, which stimulates the growth of the cancer.

Brand Name:	TUKYSA
Generic Name:	tucatinib
Strength:	• Tablets: 50 mg and 150 mg.
Manufacturer:	Seagen
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “TUKYSA (tucatinib) Tablets” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for pharma product cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

« Older Entries

Next Entries »

Contact Info

CORPORATE OFFICE:
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.

MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398

EMAIL ID:
info@indianpharmanetwork.co.in

FAX NUMBER:
+91-11-26532129

Query Form For Medications

Note

We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.

Disclaimer

“Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is intended to provide general information about consultancy services offered by IPN and to help users access this information in a user friendly format. Certain information available on the website has been sourced from publicly available sources. While Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in believes such information to be reasonably accurate, Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in has not independently verified any of this information. All information on the IPN website is of general nature and is not a substitute for medical prescription. None of the medicines or products mentioned on the IPN website are manufactured or sold by IPN Pharma Network.

Privacy Policy

Please read the following statement to learn about our information gathering and dissemination practices in relation to our consultancy services (“Services”). Note: Our privacy policy is subject to change at any time without notice. To make sure you are aware of any changes, please review this policy periodically. By visiting the Indian Pharma Network

Health Information

“All information available on the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is of general nature and is not a substitute for professional medical advice by a licensed practitioner. Indian Pharma Network (IPN) does not purport to provide any medical or health-related advice, even of general nature and therefore you should not use or consult the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in for any questions in relation to your health or medical condition.

Shipped Anti-Cancer Medicines.

Indian Pharma Network is registered medical pharmacy for Oncology Products in India. Helps you to access FDA approved Anti-Cancer-Medicines, no matter where you live. Sourcing each medicine for named patient use and overseeing every aspect of the shipping, customs and delivery. We have helped more than 6,000 patients. Send your enquiry to find the What is the cost of Anti Cancer Medicines in Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

Indian Pharma Network (IPN), New Delhi. India

Indian Pharma Network

60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016

Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398

Free Customer Support
info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in

Solid Tumors

Brand Name: Tevimbra. Generic Name: (tislelizumab-jsgr). It is used to treat non-small cell lung cancer (NSCLC), gastric and squamous oesophageal cancer.

tildrakizumab-asmn injection for subcutaneous use Initial U.S. Approval: 2018

Facts about tildrakizumab-asmn injection

Access the best support services globally

Velexbru Tablet 80mg, a Bruton’s Tyrosine Kinase Inhibitor in Japan

Access the best support services globally

tralokinumab-ldrm injection for subcutaneous use Initial U.S. Approval: 2021

Facts about tralokinumab-ldrm injection

Access the best support services globally

trastuzumab Intravenous Infusion Initial U.S. Approval: 1998

Facts about trastuzumab Intravenous Infusion

Access the best support services globally

TRIKAFTA (elexacaftor, tezacaftor and ivacaftor tablets; ivacaftor tablets), co-packaged for oral use.

Access the best support services globally

trilaciclib for injection for intravenous use Initial U.S. Approval: 2021

Facts about trilaciclib for injection

Access the best support services globally

Brand Name: TRODELVY Generic Name: sacituzumab govitecan-hziy. It is used to treat adults with a type of breast cancer known as triple-negative breast cancer.

Brand Name: TRUQAP Generic Name: capivasertibb. It is used to treat breast cancer.

Brand Name: TUKYSA. Generic Name: (tucatinib). It is used to treat breast cancer.

Contact Info

Query Form For Medications

Note

Disclaimer

Privacy Policy

Health Information

Shipped Anti-Cancer Medicines.

Indian Pharma Network (IPN), New Delhi. India

tildrakizumab-asmn injection
for subcutaneous use Initial U.S. Approval: 2018

Velexbru Tablet 80mg,
a Bruton’s Tyrosine Kinase Inhibitor in Japan

tralokinumab-ldrm injection
for subcutaneous use Initial U.S. Approval: 2021

trastuzumab
Intravenous Infusion Initial U.S. Approval: 1998

trilaciclib for injection
for intravenous use Initial U.S. Approval: 2021